Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

104
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
104
Pneumothorax-I01:26

Pneumothorax-I

154
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
154

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endobronchial ultrasound-guided mediastinal cryobiopsy: A retrospective study from two tertiary care centres in north-central India.

Lung India : official organ of Indian Chest Society·2026
Same author

Primary ovarian diffuse large B-cell lymphoma.

BMJ case reports·2026
Same author

Locoregional and symptomatic response to neoadjuvant dual HER2 blockade with chemotherapy in HER2-positive breast cancer: a pilot study.

Anti-cancer drugs·2025
Same author

Efficacy of pulmonary rehabilitation on patient-reported outcomes in interstitial lung disease: A quasi-experimental study.

Respiratory medicine·2025
Same author

Role of oscillometry to diagnose obstructive airway diseases in patients who are unable to perform spirometry correctly.

Medical journal, Armed Forces India·2025
Same author

Topiramate-induced acute eosinophilic pneumonia.

Drug and therapeutics bulletin·2025
Same journal

Tuberculosis verrucosa cutis: An easy spotter yet frequently missed!

Medical journal, Armed Forces India·2026
Same journal

Non-Hodgkin lymphoma arising in a vallecular cyst: A rare clinical entity.

Medical journal, Armed Forces India·2026
Same journal

Utility of pre-operative magnetic resonance imaging (pelvis and abdomen) and combined tumour markers HE4 and CA125 in diagnosing early and advanced carcinoma endometrium.

Medical journal, Armed Forces India·2026
Same journal

Endoscopic management of Zenker's diverticulum.

Medical journal, Armed Forces India·2026
Same journal

Epithelial ingrowth post small incision lenticule extraction: CIRCLE software to the rescue.

Medical journal, Armed Forces India·2026
Same journal

Colistin rapid NP test for detection of colistin-resistance in colistin-resistant enterobacterales.

Medical journal, Armed Forces India·2026
See all related articles

Related Experiment Video

Updated: May 7, 2025

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
06:52

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

17.1K

Docetaxel-induced lung injury.

Amit Singh Vasan1, Gurjeet Singh Chowdhary2, Indramani Pandey3

  • 1Graded Specialist (Pulmonary Medicine), Command Hospital (Western Command), Chandimandir, Haryana, India.

Medical Journal, Armed Forces India
|December 30, 2024
PubMed
Summary
This summary is machine-generated.

Docetaxel can cause rare but fatal interstitial lung disease (ILD). This case series shows three patients with pulmonary toxicity who improved with steroids, differing from severe outcomes in other studies.

Area of Science:

  • Oncology
  • Pulmonology
  • Pharmacology

Background:

  • Docetaxel is a chemotherapy agent used for various cancers, including breast, lung, and prostate.
Keywords:
DocetaxelDrug-induced pneumonitisOrganizing pneumoniaTaxane

More Related Videos

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.5K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

8.9K

Related Experiment Videos

Last Updated: May 7, 2025

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
06:52

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

17.1K
Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.5K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

8.9K
  • Docetaxel-induced interstitial lung disease (ILD) is a rare but serious adverse event associated with high mortality.
  • Identifying and managing ILD is crucial for patient outcomes.